(Q40172065)

18 September 2017

title

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients (English)

1 reference

18 September 2017

0 references

1 reference

Gordana Konjević

1

1 reference

18 September 2017

Katarina Mirjacić Martinović

2

1 reference

18 September 2017

Ana Vuletić

3

1 reference

18 September 2017

Viktor Jović

4

1 reference

18 September 2017

Vladimir Jurisić

5

1 reference

18 September 2017

Nada Babović

6

1 reference

18 September 2017

Ivan Spuzić

7

1 reference

18 September 2017

publication date

13 February 2007

1 reference

Clinical & Experimental Metastasis

18 September 2017

published in

1 reference

18 September 2017

volume

24

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

1-11

1 reference

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9043-9

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9043-9

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9043-9

Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-006-9043-9

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

21 January 2018

1 reference

12 December 2020

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

1 reference

12 December 2020

Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.

1 reference

12 December 2020

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.

1 reference

12 December 2020

Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.

1 reference

12 December 2020

The proliferation and function of human mononuclear leukocytes and natural killer cells in serum-free medium

1 reference

12 December 2020

Biology and clinical relevance of human natural killer cells

1 reference

12 December 2020

The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells

1 reference

12 December 2020

Immunological aspects of retinoids in humans. III. Effects of retinoic acid on the natural killing of tumor cells

1 reference

12 December 2020

Therapy of malignant melanoma at the stage of distant metastasis

1 reference

12 December 2020

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

12 December 2020

Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma

1 reference

12 December 2020

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

1 reference

12 December 2020

Comparative studies of human FcRIII-positive and negative natural killer cells

1 reference

12 December 2020

Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha

1 reference

12 December 2020

Interleukin-2 for the treatment of melanoma

1 reference

12 December 2020

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

12 December 2020

Human natural killer cell receptors: insights into their molecular function and structure

1 reference

12 December 2020

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells

1 reference

12 December 2020

The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.

1 reference

12 December 2020

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

1 reference

12 December 2020

Structure and function of natural-killer-cell receptors

1 reference

12 December 2020

Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients.

1 reference

12 December 2020

Antileukemia activity of a natural killer cell line against human leukemias

1 reference

12 December 2020

Retinoic acid modulation of alpha(1-->2) fucosyltransferase activity and sensitivity of tumor cells to LAK-mediated cytotoxicity

1 reference

12 December 2020

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

1 reference

12 December 2020

Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions

1 reference

12 December 2020

Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma

1 reference

12 December 2020

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

12 December 2020

The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated.

1 reference

12 December 2020

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

12 December 2020

Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690

1 reference

12 December 2020

KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation

1 reference

12 December 2020

The biology of human natural killer-cell subsets

1 reference

12 December 2020

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

12 December 2020

1 reference

12 December 2020

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

12 December 2020

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

1 reference

12 December 2020

What is a natural killer cell?

1 reference

12 December 2020

Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma

1 reference

12 December 2020

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

12 December 2020

Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.

1 reference

12 December 2020

The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.

1 reference

12 December 2020

10.1007/S10585-006-9043-9

Identifiers

DOI

1 reference

Dimensions Publication ID

18 September 2017

1038621216

0 references

Fatcat ID

release_tm22gw4s5zchhkx6f53t5hcwpe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tm22gw4s5zchhkx6f53t5hcwpe

24 November 2022

mapped directly with Wikidata item

1 reference